{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:18:33Z","timestamp":1792045113237,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00223-017-0236-9","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T03:09:58Z","timestamp":1485486598000},"page":"341-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study"],"prefix":"10.1007","volume":"100","author":[{"given":"O.","family":"Viapiana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fassio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Orsolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"236_CR1","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","volume":"387","author":"A Forlino","year":"2016","unstructured":"Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet Lond Engl 387:1657\u20131671. doi: 10.1016\/S0140-6736(15)00728-X","journal-title":"Lancet Lond Engl"},{"key":"236_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7:540\u2013557. doi: 10.1038\/nrendo.2011.81","journal-title":"Nat Rev Endocrinol"},{"key":"236_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10354-015-0361-x","volume":"165","author":"H Hoyer-Kuhn","year":"2015","unstructured":"Hoyer-Kuhn H, Netzer C, Semler O (2015) Osteogenesis imperfecta: pathophysiology and treatment. Wien Med Wochenschr 1946 165:278\u2013284. doi: 10.1007\/s10354-015-0361-x","journal-title":"Wien Med Wochenschr"},{"key":"236_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1203\/00006450-198303000-00007","volume":"17","author":"R Baron","year":"1983","unstructured":"Baron R, Gertner JM, Lang R, Vignery A (1983) Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res 17:204\u2013207. doi: 10.1203\/00006450-198303000-00007","journal-title":"Pediatr Res"},{"key":"236_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","volume":"34","author":"V Braga","year":"2004","unstructured":"Braga V, Gatti D, Rossini M et al (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013\u20131016. doi: 10.1016\/j.bone.2004.02.023","journal-title":"Bone"},{"key":"236_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900670","volume":"65","author":"C Cepollaro","year":"1999","unstructured":"Cepollaro C, Gonnelli S, Pondrelli C et al (1999) Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters. Calcif Tissue Int 65:129\u2013132","journal-title":"Calcif Tissue Int"},{"key":"236_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/jbmr.5650100222","volume":"10","author":"S Minisola","year":"1995","unstructured":"Minisola S, Rosso R, Romagnoli E (1995) Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 10:335\u2013339. doi: 10.1002\/jbmr.5650100222","journal-title":"J Bone Miner Res"},{"key":"236_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/jbmr.5650090706","volume":"9","author":"RE Brenner","year":"1994","unstructured":"Brenner RE, Vetter U, Bollen AM et al (1994) Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993\u2013997. doi: 10.1002\/jbmr.5650090706","journal-title":"J Bone Miner Res"},{"key":"236_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s007740200025","volume":"20","author":"J Iwamoto","year":"2002","unstructured":"Iwamoto J, Takeda T, Ichimura S (2002) Increased bone resorption with decreased activity and increased recruitment of osteoblasts in osteogenesis imperfecta type I. J Bone Miner Metab 20:174\u2013179. doi: 10.1007\/s007740200025","journal-title":"J Bone Miner Metab"},{"key":"236_CR10","doi-asserted-by":"crossref","first-page":"239249","DOI":"10.1097\/00003086-197306000-00024","volume":"93","author":"S Castells","year":"1973","unstructured":"Castells S (1973) New approaches to treatment of osteogenesis imperfecta. Clin Orthop 93:239\u2013249","journal-title":"Clin Orthop"},{"key":"236_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/jcem.76.1.8421094","volume":"76","author":"JC Marini","year":"1993","unstructured":"Marini JC, Bordenick S, Heavner G et al (1993) The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J Clin Endocrinol Metab 76:251\u2013256. doi: 10.1210\/jcem.76.1.8421094","journal-title":"J Clin Endocrinol Metab"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EJE-10-0208","volume":"163","author":"F Antoniazzi","year":"2010","unstructured":"Antoniazzi F, Monti E, Venturi G, et al (2010) GH in combination with bisphosphonate treatment in osteogenesis imperfecta. Eur J Endocrinol 163:479\u2013487. doi: 10.1530\/EJE-10-0208","journal-title":"Eur J Endocrinol"},{"key":"236_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/TCRM.S35788","volume":"9","author":"D Gatti","year":"2013","unstructured":"Gatti D, Rossini M, Viapiana O et al (2013) Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag 9:139\u2013147. doi: 10.2147\/TCRM.S35788","journal-title":"Ther Clin Risk Manag"},{"key":"236_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll ES, Shapiro J, Veith S et al (2014) Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest 124:491\u2013498. doi: 10.1172\/JCI71101","journal-title":"J Clin Invest"},{"key":"236_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","volume":"97","author":"EM Horwitz","year":"2001","unstructured":"Horwitz EM, Prockop DJ, Gordon PL et al (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227\u20131231","journal-title":"Blood"},{"key":"236_CR16","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2014-3072","volume":"99","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, Semler O, Schoenau E (2014) Effect of denosumab on the growing skeleton in osteogenesis imperfecta. J Clin Endocrinol Metab 99:3954\u20133955. doi: 10.1210\/jc.2014-3072","journal-title":"J Clin Endocrinol Metab"},{"key":"236_CR17","doi-asserted-by":"publisher","first-page":"CD005088","DOI":"10.1002\/14651858.CD005088.pub3","volume":"7","author":"K Dwan","year":"2014","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D (2014) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 7:CD005088. doi: 10.1002\/14651858.CD005088.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"236_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","volume":"18","author":"S Adami","year":"2003","unstructured":"Adami S, Gatti D, Colapietro F et al (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126\u2013130. doi: 10.1359\/jbmr.2003.18.1.126","journal-title":"J Bone Miner Res"},{"key":"236_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R et al (2005) Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20:758\u2013763. doi: 10.1359\/JBMR.041232","journal-title":"J Bone Miner Res"},{"key":"236_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2410","volume":"30","author":"JD Hald","year":"2015","unstructured":"Hald JD, Evangelou E, Langdahl BL, Ralston SH (2015) Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials. J Bone Miner Res 30:929\u2013933. doi: 10.1002\/jbmr.2410","journal-title":"J Bone Miner Res"},{"key":"236_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jbmr.5650100402","volume":"10","author":"S Adami","year":"1995","unstructured":"Adami S, Kanis JA (1995) Assessment of involutional bone loss: methodological and conceptual problems. J Bone Miner Res 10:511\u2013517. doi: 10.1002\/jbmr.5650100402","journal-title":"J Bone Miner Res"},{"key":"236_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1359\/JBMR.051015","volume":"21","author":"G Chevrel","year":"2006","unstructured":"Chevrel G, Schott A-M, Fontanges E et al (2006) Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. J Bone Miner Res 21:300\u2013306. doi: 10.1359\/JBMR.051015","journal-title":"J Bone Miner Res"},{"key":"236_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00198-011-1658-2","volume":"23","author":"LA Bradbury","year":"2012","unstructured":"Bradbury LA, Barlow S, Geoghegan F, et al (2012) Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists. Osteoporos Int 23:285\u2013294. doi: 10.1007\/s00198-011-1658-2","journal-title":"Osteoporos Int"},{"key":"236_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2920","author":"L Folkestad","year":"2016","unstructured":"Folkestad L, Hald JD, Ersb\u00f8ll AK et al (2016) Fracture rates and fracture sites in patients with osteogenesis imperfecta: A Nationwide Register-Based Cohort Study. J Bone Miner Res. doi: 10.1002\/jbmr.2920","journal-title":"J Bone Miner Res"},{"key":"236_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.5037\/jomr.2013.4401","volume":"4","author":"AA Hennedige","year":"2013","unstructured":"Hennedige AA, Jayasinghe J, Khajeh J, Macfarlane TV (2013) Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. J Oral Maxillofac Res 4:e1. doi: 10.5037\/jomr.2013.4401","journal-title":"J Oral Maxillofac Res"},{"key":"236_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00774-011-0331-3","volume":"30","author":"E Maines","year":"2012","unstructured":"Maines E, Monti E, Doro F et al (2012) Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. J Bone Miner Metab 30:434\u2013438. doi: 10.1007\/s00774-011-0331-3","journal-title":"J Bone Miner Metab"},{"key":"236_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11832-011-0380-0","volume":"6","author":"N Nicolaou","year":"2012","unstructured":"Nicolaou N, Agrawal Y, Padman M et al (2012) Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates. J Child Orthop 6:21\u201327. doi: 10.1007\/s11832-011-0380-0","journal-title":"J Child Orthop"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0236-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:09:45Z","timestamp":1498367385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0236-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0236-9","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}